Tag: Peptide-Based Gastrointestinal Disorders Therapeutics Market

Peptide-Based Gastrointestinal Disorders Therapeutics Market: Segmentation Application, Technology & Market Analysis Report 2018-2026

Coherent Market Insights released a new market study on 2018-2026 Peptide-Based Gastrointestinal Disorders Therapeutics Market with 100+ market data Tables, Pie Chat, Graphs & Figures spread through Pages and easy to understand detailed analysis. At present, the market is developing its presence. The Research report presents a complete assessment of the Market and contains a…
Read more

Peptide-Based Gastrointestinal Disorders Therapeutics Market Value Projected to Expand by 2018-2026

Peptides are short chains of amino acid monomers linked by┬ápeptide (amide) bonds. Peptide-based gastrointestinal (GIT) disorders therapeutics are drugs that are used for the treatment of various GIT disorders such as short bowel syndrome, chronic constipation, and irritable bowel syndrome. In the recent past, some peptide-based therapeutics such as Trulance, Linaclotide, and Teduglutide received approval…
Read more